Sun M, Kingdom J, Baczyk D, Lye S J, Matthews S G, Gibb W
Department of Obstetrics and Gynecology and Cellular and Molecular Medicine, University of Ottawa, Canada.
Placenta. 2006 Jun-Jul;27(6-7):602-9. doi: 10.1016/j.placenta.2005.05.007. Epub 2005 Sep 6.
The multidrug resistance p-glycoprotein (P-gp), encoded by the ABCB1 gene, is a plasma membrane protein that actively extrudes a wide variety of substances from cells. Preliminary studies in mice have shown that the ABCB1/P-gp can protect the fetus from a number of toxic substances. ABCB1/P-gp is expressed in the human placenta and is potentially capable of protecting the fetus from a large number of drugs and toxins, including herbicides and pesticides. The protein can also extrude various steroids including certain glucocorticoids and may therefore play an important role in regulating fetal access of glucocorticoids. The aim of the present study was to examine the expression profile and cellular localization of ABCB1/P-gp in human placenta throughout gestation. We hypothesized that there would be gestational age-related changes in the expression of the protein. ABCB1/P-gp mRNA was measured by Real-Time PCR using specific probes in tissues obtained from 6 weeks gestation to term. ABCB1/P-gp mRNA levels in placental tissue obtained at 6-10 weeks (n=5) and 24-35 weeks (n=5) were significantly higher than in tissues obtained at term (38-41 weeks gestation) by elective C-section (n=6) or following labor (n=6). The profile of ABCB1/P-gp protein levels, quantified using Western analysis, demonstrated a similar decrease with advancing gestation. At all gestational ages ABCB1/P-gp was localized by immunohistochemistry to the syncytiotrophoblast. In term tissues, it appeared to be localized to some areas of the villi and not others. Together, these data indicate that with advancing gestation there is a decrease in the level of ABCB1/P-gp in the human placenta indicating that the fetus may be more susceptible to toxic insults in the latter part of gestation. Further, the reduction in ABCB1/P-gp expression may contribute to the increased transfer of maternal cortisol to the fetus that is known to occur in late gestation.
由ABCB1基因编码的多药耐药性P-糖蛋白(P-gp)是一种质膜蛋白,可将多种物质主动排出细胞。对小鼠的初步研究表明,ABCB1/P-gp可保护胎儿免受多种有毒物质的侵害。ABCB1/P-gp在人胎盘中表达,有可能保护胎儿免受大量药物和毒素的侵害,包括除草剂和杀虫剂。该蛋白还可排出包括某些糖皮质激素在内的各种类固醇,因此可能在调节胎儿对糖皮质激素的摄取中起重要作用。本研究的目的是检查整个妊娠期人胎盘中ABCB1/P-gp的表达谱和细胞定位。我们假设该蛋白的表达会有与胎龄相关的变化。使用特异性探针通过实时定量PCR测定从妊娠6周直至足月获取的组织中ABCB1/P-gp mRNA的含量。通过择期剖宫产(n = 6)或分娩后(n = 6)获取的足月(妊娠38 - 41周)胎盘组织中ABCB1/P-gp mRNA水平显著低于妊娠6 - 10周(n = 5)和24 - 35周(n = 5)获取的胎盘组织。使用蛋白质免疫印迹法量化的ABCB1/P-gp蛋白水平谱显示,随着妊娠进展有类似的下降。在所有胎龄,通过免疫组织化学法将ABCB1/P-gp定位于合体滋养层。在足月组织中,它似乎定位于绒毛的某些区域而非其他区域。总之,这些数据表明,随着妊娠进展,人胎盘中ABCB1/P-gp水平降低,这表明胎儿在妊娠后期可能更容易受到有毒侵害。此外,ABCB1/P-gp表达的降低可能导致已知在妊娠后期发生的母体皮质醇向胎儿的转运增加。